These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 32196745)

  • 1. Caution of variability: Domain-specific cognition measured by Montreal Cognitive Assessment in normal ageing and prodromal dementia.
    Lu H
    Int J Geriatr Psychiatry; 2020 Jun; 35(6):686-687. PubMed ID: 32196745
    [No Abstract]   [Full Text] [Related]  

  • 2. Associations between intra-individual variability and Montreal Cognitive Assessment (MoCA) in cognitive ageing and prodromal dementia: A domain-specific perspective.
    Lu H; Lam LCW
    Parkinsonism Relat Disord; 2018 Mar; 48():102-103. PubMed ID: 29174196
    [No Abstract]   [Full Text] [Related]  

  • 3. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease.
    Hendershott TR; Zhu D; Llanes S; Zabetian CP; Quinn J; Edwards KL; Leverenz JB; Montine T; Cholerton B; Poston KL
    Mov Disord; 2019 Feb; 34(2):285-291. PubMed ID: 30776152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of 'two-level' variability on the differential power for Montreal Cognitive Assessment (MoCA) in prodromal dementia.
    Lu H; Lam LC
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):186-187. PubMed ID: 27521376
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison between the Mini-Mental State Examination and Montreal Cognitive Assessment in assessing cognitive function in patients with diabetes-related dementia.
    Yamakawa H; Okita M; Fukasawa R; Hatanaka H; Namioka N; Hanyu H
    Psychogeriatrics; 2018 Jan; 18(1):72-73. PubMed ID: 28664625
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation of the Sinhala Version of the Addenbrooke's Cognitive Examination-Revised for the Detection of Dementia in Sri Lanka: Comparison with the Mini-Mental Status Examination and the Montreal Cognitive Assessment.
    Suriyakumara V; Srikanth S; Wijeyekoon R; Gunasekara H; Muthukuda C; Rajapaksha D; Weerasekara R; Gonawala L; Wijekoon N; de Silva KRD
    Dement Geriatr Cogn Disord; 2019; 47(4-6):198-208. PubMed ID: 31311022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent application of montreal cognitive assessment/mini-mental state examination conversion.
    Armstrong MJ; Duff-Canning S; Psych C; Kowgier M; Marras C
    Mov Disord; 2015 Oct; 30(12):1710-1. PubMed ID: 25820874
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparing the Montreal Cognitive Assessment and Rowland Universal Dementia Assessment Scale in a multicultural rehabilitation setting.
    Emerson A; Muruganantham P; Park MY; Pillay D; Vasan N; Park SJ; Van KL; Pampapathi P; Seow CS; Yau SM
    Intern Med J; 2019 Aug; 49(8):1035-1040. PubMed ID: 31387144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the performance of the Montreal Cognitive Assessment in early stage Parkinson's disease.
    Kletzel SL; Hernandez JM; Miskiel EF; Mallinson T; Pape TL
    Parkinsonism Relat Disord; 2017 Apr; 37():58-64. PubMed ID: 28189463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
    Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
    Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS; Huang J; Chowdhury MH
    J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Sensitivity of the Mini-Mental State Examination for Cognitive Assessment of Brazilian Patients With Parkinson Disease.
    Breder R; Leite MAA; Pinto JA; Cavalcante IP; Pessoa BL; Neves MAO
    J Geriatr Psychiatry Neurol; 2017 Nov; 30(6):311-315. PubMed ID: 28969462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further study of the Montreal Cognitive Assessment's domain-specific metrics could allow for international data comparison and collaboration.
    Hendershott TR; Poston KL
    Parkinsonism Relat Disord; 2018 Mar; 48():101. PubMed ID: 29221675
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing cognition in Parkinson disease: use of the cognitive linguistic quick test.
    Parashos SA; Johnson ML; Erickson-Davis C; Wielinski CL
    J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):228-34. PubMed ID: 19666882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microstructural damage of normal-appearing white matter in subcortical ischemic vascular dementia is associated with Montreal Cognitive Assessment scores.
    Liao Z; Dang C; Li M; Bu Y; Han R; Jiang W
    J Int Med Res; 2019 Nov; 47(11):5723-5731. PubMed ID: 31342825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Montreal Cognitive Assessment and Discriminant Power of Montreal Cognitive Assessment Subtests in Patients With Mild Cognitive Impairment and Alzheimer Dementia in Turkish Population.
    Kaya Y; Aki OE; Can UA; Derle E; Kibaroğlu S; Barak A
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):103-9. PubMed ID: 24578463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild Cognitive Impairment and Dementia Involving Multiple Cognitive Domains in Mexican Urbanites.
    Calderón-Garcidueñas L; Mukherjee PS; Kulesza RJ; Torres-Jardón R; Hernández-Luna J; Ávila-Cervantes R; Macías-Escobedo E; González-González O; González-Maciel A; García-Hernández K; Hernández-Castillo A; Villarreal-Ríos R;
    J Alzheimers Dis; 2019; 68(3):1113-1123. PubMed ID: 30909241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.